Trial Information
Inclusion Criteria
Inclusion criteria:
- in order to be eligible for the study, the diagnosis of gastric cancer and/or lower
esophageal cancer must be confirmed histologically. CNS involvement must be confirmed
either via independent neuroradiological and/or positive CSF cytology.
Exclusion criteria:
- Patients whose diagnosis is not confirmed upon pathological review or where the CNS
involvement cannot be confirmed after neuroradiological review will be excluded from
this study.
Type of Study:
Observational
Study Design:
Observational Model: Case-Only
Principal Investigator
01 Studienregister MasterAdmins
Investigator Role:
Study Director
Investigator Affiliation:
UniversitaetsSpital Zuerich
Authority:
Switzerland: Swissmedic
Study ID:
UGICNS
NCT ID:
NCT01456455
Start Date:
August 2011
Completion Date:
April 2016
Related Keywords:
- Upper Gastrointestinal (UGI) Cancer
- CNS
- pathological markers